MSD Commited to bringing out the best in medicine
Contact UsWorldwide
   
Email Updates
Request More Information

 

Key Publications

Articles provided on this website or that are linked to or from this website are owned by third parties and protected by copyright laws. Authorized users have permission to download, display, view and print a single copy for their personal use for research and private study purposes. Any other use is prohibited unless permission is obtained from the copyright owner. Authorized users may not remove, alter, or modify any part of the article, including the authors' names and copyright notices.

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
DB Price Thorax Vol. 58, 2003, Pages 211-216
View full article
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
MJ Vaquerizo Thorax Vol. 58, 2003, Pages 204-210
View full article
PrintPrint
SINGULAIR (montelukast sodium) is a registered trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA.
Copyright © 2004 Merck & Co., Inc., All rights reserved.
LATEST ARTICLES
CASIOPEA
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
View article 
COMPACT
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
View article
Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA) Disclaimer